These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4651200)

  • 1. [Indications for cytostatic treatment of patients with osteomyelosclerosis of osteomyelofibrosis].
    Engelmann C; Schulz K; Nowotny P; Konrad H
    Dtsch Gesundheitsw; 1972 Dec; 27(50):2375-80. PubMed ID: 4651200
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tactics of cytostatic therapy of primary and secondary (post-erythremic) myelofibrosis].
    Demidova AV; Sysoeva NA
    Probl Gematol Pereliv Krovi; 1976 Jul; 21(7):23-7. PubMed ID: 1071792
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of cytostatic and radiologic treatment of chronic myelocytic leukemia (analysis of 11 cases)].
    Maurice PA
    Rev Med Suisse Romande; 1970 Jun; 90(6):521-32. PubMed ID: 5293581
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical aspects of osteomyelofibrosis and osteomyelosclerosis].
    Engelmann C; Schulz K; Nowotny P; Konrad H
    Z Gesamte Inn Med; 1975 May; 30(9):326-30. PubMed ID: 1224743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of osteomyelosclerosis and osteomyelofibrosis].
    Treske U
    Dtsch Med Wochenschr; 1970 Aug; 95(33):1691-2. PubMed ID: 5447788
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of myeloproliferative diseases.
    Sellei C
    Ther Hung; 1966; 14(4):135-6. PubMed ID: 5228101
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of AGL.
    Lee SL; Rosner F
    Arch Intern Med; 1969 Feb; 123(2):205-6. PubMed ID: 5249563
    [No Abstract]   [Full Text] [Related]  

  • 8. Myelofibrosis: response to busulfan after hydroxyurea failure.
    Naqvi T; Baumann MA
    Int J Clin Pract; 2002 May; 56(4):312-3. PubMed ID: 12074218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic myeloid leukaemia: course, life expectancy, and an analysis of dibromomannitol and busulfan treatment.
    Gerhartz H
    Haematologica; 1972 Apr; 57(11):775-86. PubMed ID: 4200312
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cytostatics in the treatment of nephritides].
    Tarejew EM; Muchin NA; Poljanzewa LR; Tarejewa IE
    Dtsch Gesundheitsw; 1970 Oct; 25(44):2068-71. PubMed ID: 5491290
    [No Abstract]   [Full Text] [Related]  

  • 11. Results in the treatment of chronic myeloid leukaemia.
    Nasr AL; Aboul-Enein M; Tawfik HN
    Haematologica; 1972 Apr; 57(11):794-802. PubMed ID: 4200314
    [No Abstract]   [Full Text] [Related]  

  • 12. [The therapy of hemoblastosis and malignant lymphoma. I. Leukosis, polycythemia vera and osteomyelosclerosis].
    Löffler H; Schultis K
    Med Welt; 1968 Jan; 1():96-100. PubMed ID: 5704123
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment procedures in myelofibrosis].
    Klimova NF
    Probl Gematol Pereliv Krovi; 1978; 23(11):31-5. PubMed ID: 714890
    [No Abstract]   [Full Text] [Related]  

  • 14. [Progress in the therapy of leukoses].
    Stacher A
    Wien Med Wochenschr; 1970 Jun; 120(24):441-3. PubMed ID: 5286401
    [No Abstract]   [Full Text] [Related]  

  • 15. [Attempts of the use of cytostatic agents in some forms of glomerulonephritis in children].
    Nowak S; Bodalski J; Margolis A; Michalak A
    Pediatr Pol; 1969 May; 44(5):549-60. PubMed ID: 5791319
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversal of osteomyelosclerosis-associated systemic lupus nephritis.
    Vora BJ; Byers RJ; Lucas GS; Gokal R
    Nephrol Dial Transplant; 1998 Jun; 13(6):1559-61. PubMed ID: 9641195
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preliminary results of myelobromol treatment of chronic granulocytic leukemia].
    Urasiński I; Mysik M
    Wiad Lek; 1971 Jul; 24(3):271-4. PubMed ID: 5279032
    [No Abstract]   [Full Text] [Related]  

  • 18. [Choice of therapy and overall survival in patients with chronic myeloproliferative diseases].
    Rukavitsyn OA; Pop VP; Seriakov AP
    Vopr Onkol; 2004; 50(4):435-9. PubMed ID: 15605767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mycological studies in osteomyelosclerosis].
    Sobótka S; Knap J; Sobótka W
    Pol Tyg Lek; 1970 Nov; 25(47):1804-5. PubMed ID: 5484518
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the effect of a new cytostatic drug in chronic myeloses and polycythemias].
    Böhnel J; Stacher A
    Wien Med Wochenschr; 1968 Sep; 118(37):721-3. PubMed ID: 5248360
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.